Riskpilot← Back to searchSign inGet full accessNaprapat Leipe AB
ABActiveOrg 5592268139Hemvägen 17 FPhysiotherapy activities · NACE 8695Est. 20191 employees
Revenue 2025
SEK 125K
+4% vs 2024
EBITDA margin
46.4%
-39% vs 2024
Equity ratio
39.7%
Financial strength
Net profit 2025
SEK 126K
-49% vs 2024
| Revenue | SEK 125K | +4% |
| EBITDA | SEK 58K | -39% |
| Net profit | SEK 126K | -49% |
| Total assets | SEK 980K | +2% |
| Equity | SEK 389K | +20% |
| Employees | 1 | — |
Legal name
Naprapat Leipe AB
Org number
5592268139
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
14 november 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva manuell behandling och rehab av fysiska besvär och tillstånd relaterade till rörelseapparaten samt därmed förenlig verksamhet.
Address
Hemvägen 17 F
Email
idaleipe@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 640 | 197 | 313 | 120 | 125 |
| Staff expenses | — | −51 | −180 | −35 | −39 |
| EBITDA | −19 | −4 | 40 | 95 | 58 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −19 | −4 | 40 | 95 | 58 |
| Net financials | — | −0 | −23 | 167 | 78 |
| Profit before tax | −19 | −4 | 17 | 262 | 136 |
| Tax | −0 | — | −4 | −13 | −10 |
| Net profit | −19 | −4 | 13 | 248 | 126 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 164 | 127 | 875 | 962 | 980 |
| Equity | 108 | 103 | 117 | 325 | 389 |
| Long-term debt | 0 | — | 737 | 525 | 451 |
| Short-term debt | 56 | 23 | 21 | 111 | 140 |
| Total debt | 56 | 23 | 758 | 636 | 591 |
EBITDA margin
46.4%
This company
15.8%
Market median
+194% vs market
20212025
Equity ratio
39.7%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
32.4%
This company
18.4%
Market median
+76% vs market
20212025
Net profit margin
100.8%
This company
8.1%
Market median
+1144% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapat Leipe AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ida Ellinor Leipe | Board of Directors | 0 companies |
| Mikael Sansone | Deputy Board Member | 0 companies |
| Felix Teodor Pettersson | Deputy Board Member | 0 companies |